FitLife Brands, Inc. (FTLF) Fair Value 2026

FTLF · Medicinal Chemicals & Botanical Products ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

9.1 /10

32 fundamental signals · 11 models active

Value Trap Risk

LOW (31/100)

Quick Summary — As of 2026-07-13, FitLife Brands, Inc. (FTLF) trades at $11.19, approximately 47% above CirclFi’s Bayesian DCF fair value of $7.62. QOC: 9.1/10. Value Trap Risk: 31/100 (LOW). 11/13 models active.

Key Facts

Ticker
FTLF
Price
$11.19
Quality Score
9.1/10
Value Trap Risk
31/100
Models Active
11/13
Last Updated
Strength: First Chicago suggests +33.4% upside with 55% confidence
Risk: Majority of models suggest overvaluation

Valuation Matrix

11 Intrinsic Value Models vs. Current Price ($11.19)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$7.62 -31.9%
Earnings Power Value
High Conviction
$5.25 -53.1%
CUCE Ensemble
Medium Conviction
$9.37 -16.2%
First Chicago
High Conviction
$14.93 +33.4%

Unlock the Full Matrix

Access 7 additional models including EROIC Spread, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 11 Models →

Cancel anytime · No contracts · Instant access

What Is FitLife Brands, Inc. (FTLF) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, FitLife Brands, Inc.'s intrinsic value is estimated at a composite fair value of $9.31. Trading at $11.19, the stock is approaching fair value or slight overvaluation (implied return of -16.8%), as 7 of 11 models suggest limited further upside. The most optimistic model, First Chicago, places fair value at $14.93 (+33.4%), while EROIC — the most conservative — estimates $4.85 (-56.6%). This +90.1% gap reflects genuine analytical uncertainty about FitLife Brands, Inc.'s intrinsic worth. Among models with highest confidence, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About FTLF?

11 of 13 models are currently active for FTLF. Of these, 2 models suggest upside while 9 models suggest overvaluation. The Bayesian DCF estimates FTLF's intrinsic value at $7.62, implying -31.9% downside from the current price. See which stocks rank higher →

How Does FTLF Rank in Medicinal Chemicals & Botanical Products?

Among 17 Medicinal Chemicals & Botanical Products stocks, FTLF ranks #2 by Quality of Company score. CirclFi's QOC score of 9.1/10 evaluates 32 fundamental signals. A score of 9.1 places FTLF in the top tier.

FitLife Brands, Inc.'s positioning within the Medicinal Chemicals & Botanical Products segment means that capacity utilization rate plays an outsized role in fundamental analysis. The sector's unique characteristics — including automation and productivity gains — shape both the opportunity set and risk profile.

Is FTLF a Value Trap?

CirclFi's Value Trap algorithm assigns FTLF a score of 31/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

11 of 13 models are active for FitLife Brands, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, FitLife Brands, Inc. earns a quality score of 9.1/10. This exceptional rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +90.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every FTLF valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across FTLF's 11 active models, average confidence is 46%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy FitLife Brands, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medicinal Chemicals & Botanical Products Stocks Should You Also Analyze?

8 related Medicinal Chemicals & Botanical Products stocks with 13-model coverage

Read investment analysis: NAGE · USNA · BTMD · TLRY · MTEX

Frequently Asked Questions About FitLife Brands, Inc.

What is FitLife Brands, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, FitLife Brands, Inc. (FTLF) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $7.62. The Quality of Company score is 9.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is FTLF overvalued or undervalued right now?

At $11.19, 2 of 11 active models suggest FTLF may be undervalued, while 9 indicate potential overvaluation. The assessment depends on which methodology best fits FitLife Brands, Inc.'s business model in Medicinal Chemicals & Botanical Products.

What does a Quality of Company score of 9.1 mean for FTLF?

FitLife Brands, Inc.'s QOC of 9.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on FTLF?

CirclFi analyzes FTLF with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 11 of 13 are active for this stock. Read the full methodology →

Is FTLF a value trap in 2026?

FitLife Brands, Inc.'s Value Trap score is 31/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 11 mathematical frameworks give you clarity on FTLF.

Unlock All 11 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access